Activation of the lnc RNA XLOC_006390/c-MYC also increases GDH1 mRNA expression and promotes glutamate metabolism, which is associated with poor survival in PC patients and is a potential therapeutic target for PC (He et al., 2020). Here, MYC is linked to pachyonychia congenita.